Loading…
This event has ended. Create your own event on Sched.
Welcome to the Science Summit at UNGA76, a major contribution to advancing Science for the UN SDGs. Online from 14- September - 5 October 2021.
ISC will organise the second edition of the UNGA76 Science Summit around the 76th United Nations General Assembly (SSUNGA76) in September 2021. The objective of the virtual meeting will be to raise awareness of the role and contribution of science to the attainment of the United Nations Sustainable Development Goals. It will demonstrate initiatives that provide models for global science mechanisms and activities in support of the SDGs, particularly in science infrastructure and capacity building. Science is and will enable sustainable economic, environmental, and societal development. Science is more than a funding prioritisation exercise: science is impacting all areas of policy-making and is playing a more critical role in how policy objectives are achieved and the consequent benefit to people everywhere, including responses to global challenges.
Engagement with policy leadership is more important than ever: UNGA76 is a unique forum for science to demonstrate how policy and political leadership can benefit from innovation. Central to this is the role of nonstate actors and the multilateral fora, which increasingly determine how priorities are set. Science needs to be part of this dialogue and inform outputs through thought leadership, evidence, insights, analysis, and innovation.

Registration is available here.
Back To Schedule
Wednesday, September 22 • 3:00pm - 6:00pm
(REF CT22) EDCTP: an EU-Africa partnership advancing global health research and cooperation

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.

The European & Developing Countries Clinical Trials Partnership (EDCTP) is a public-public partnership between 16 African and 14 European countries that aims to accelerate the development of new or improved medical interventions for the identification, treatment and prevention of infectious diseases, including emerging/re-emerging diseases. Launched in 2003 and renewed in 2014, EDCTP has been the focal point of European Union (EU) support for global health research in Africa, and a visible sign of commitment first to the Millennium Development Goals and then to the Sustainable Development Goals (SDGs). EDCTP actively contributes to the United Nations 2030 Agenda for Sustainable Development and its associated SDGs, most directly to SDG3 (‘Ensure healthy lives and promote well-being for all at all ages) but also to SDG1 (‘End poverty in all its forms everywhere).

Clinical trials supported by the second EDCTP programme (EDCTP2; 2014-2024) involve international collaborations spanning across over 60 countries and 350 institutions in Europe and sub-Saharan Africa, with broader global collaboration. By June 2021, the EDCTP2 portfolio comprised 416 grants awarded through 60 Calls for Proposals, representing a total investment of EUR 810 million. Results from EDCTP-funded clinical trials have generated pivotal evidence which will be translated into policy and implemented in practice by the appropriate partners, ensuring greater global health impact. Due to launch in the first quarter of 2022, the future EDCTP programme (Global Health EDCTP3) will retain its focus on poverty-related infectious diseases affecting sub-Saharan Africa, but it will have additional resources and a stronger commitment to collaborative and coordinated approaches to address them, working with global and regional partners to tackle existing and emerging infectious disease threats. It will also continue to strengthen the enabling environment for conducting clinical research capacity in the region. Building on the foundation laid by the two previous EDCTP programmes, the partnership will ensure that more people gain access to new medical interventions and help to protect and strengthen regional and global health security.
On the occasion of the 76th United Nations General Assembly, this side meeting will aim to advance the broader discussion on how to ensure sustained support and advancement along the continuum of product development for infectious diseases, including scale-up, implementation and access in sub-Saharan Africa and globally, in the pursuit of achieving the health-related targets of the 2030 Agenda for Sustainable Development. The objectives of the session will be to:
  • Showcase how EDCTP contributes to the SDGs and the 2030 Agenda for Sustainable Development
  • Galvanise global policy support for Global Health EDCTP3, to increase awareness and build engagement with prospective partners
  • Develop input on the United Nations roadmap for digital cooperation, including alignment with the EU’s digital transformation agenda for the EU and Africa
  • Address health research obstacles including data governance, particularly access to and use of data by developing countries
  • Further, discuss recommendations on clinical trial infrastructure and capacity building in Africa arising from a session hosted by the European Clinical Infrastructure Networks (ECRIN) and EDCTP on 17 June 2021 at the Africa-Europe Science and Innovation Summit
  • Highlight the evolution of EDCTP into Global Health.
 
 
Agenda 
 
EDCTP: An EU-Africa partnership advancing global health research and cooperation
 
Chairs:   Marcel Tanner, EDCTP High Representative (Europe)
Leonardo Simão, EDCTP High Representative (Africa)

15:00-15:15 Welcome and session presentation from the co-Chairs, followed by opening remarks from:
Catarina Resende de Oliveira, Agency for Clinical Research and Biomedical Innovation (AICIB), Portugal
Daan du Toit, South African Department of Science and Innovation, South Africa (EDCTP General Assembly representative for South Africa)
Pedro Alonso, World Health Organization, Switzerland
Anthony Solomon, World Health Organization, Switzerland
Barbara Kerstiëns, European Commission, Belgium.

15:15-15:30 Keynote address - a global policy framework for global health and clinical trials, Marleen Temmerman, Aga Khan University, Kenya

15:30-15:45 EDCTP’s investment in global health and clinical trials: current progress and future perspective, Michael Makanga, EDCTP, the Netherlands

15:45-16:00 The importance of capacity development for advancing global health, research and development, Peter Kilmarx, Fogarty International Center, National Institutes of Health, USA

16:00-16:15 Data governance and fostering an enabling regulatory environment for global health and clinical trials, Margareth Ndomondo-Sigonda, AUDA-NEPAD, South Africa

16:15-16:40 Panel discussion on synergies with and between European Union and United Nations funding and policy instruments
Ruxandra Draghia-Akli, Johnson & Johnson, USA
Nkandu Luo, EDCTP General Assembly Representative, Zambia
Melinda Moree, Bill & Melinda Gates Foundation, USA
Seamus O’Brien, Global Antibiotic Research & Development Partnership (GARDP), Switzerland
Magda Robalo Correia e Silva, High Commissioner for COVID-19, Guinea-Bissau

16:40-16:55 Audience Q&A and discussion

16:55-17:00 Wrap-up and closing remarks


Speakers
avatar for Seamus O’Brien

Seamus O’Brien

R&D Director, Global Antibiotic Research and Development Partnership (GARDP), Switzerland
Seamus O’Brien joined the Global Antibiotic Research and Development Partnership (GARDP) as R&D Director in July 2018 and is responsible for strategic development and delivery of the antibiotic R&D portfolio. Currently he is also interim lead for the STI programme area and the zolifodacin... Read More →
avatar for Melinda Moree

Melinda Moree

Senior Program Officer, Global Health R&D, Global Policy and Advocacy,, Bill & Melinda Gates Foundation, USA
avatar for Ruxandra Draghia-Akli

Ruxandra Draghia-Akli

Global Head, Johnson & Johnson Global Public Health R&D, USA
Ruxandra Draghia-Akli is Global Head, Johnson & Johnson Global Public Health R&D, where her and her team advance global public health into the next era of innovation through discovery, development, and technology capabilities. She accelerates GPH’s end-to-end strategy by collaborating... Read More →
avatar for Anthony Solomon

Anthony Solomon

Chief Scientist, Department of Control of Neglected Tropical Diseases, World Health Organization (WHO)
Dr Anthony Solomon PhD FRCP, is an infectious diseases physician and epidemiologist. He is Chief Scientist in the Department of Control of Neglected Tropical Diseases at WHO. His main research interest has been to generate evidence for best practice in the control and elimination... Read More →
avatar for Barbara Kerstiëns

Barbara Kerstiëns

Head of Unit “Combatting Diseases” within the Directorate-General for Research and Innovation, European Commission
Barbara Kerstiëns, MD, MPH is the Head of Unit in the unit responsible for ‘Combatting Diseases’ in the PEOPLE Directorate of the Directorate-General for Research and Innovation at the European Commission.She has a long experience in international public health, working for Médecins... Read More →
avatar for Michael Makanga

Michael Makanga

Director, European Development Countries Clinical Trails Partnership (EDCTP)
Dr. Michael Makanga, MD PhD FRCP: EDCTP Executive Director.Dr. Makanga is a clinician-scientist with 27 years of professional experience of working on health and poverty-related infectious diseases in Africa. This includes 23 years of work experience on medical product development... Read More →
avatar for Daan du Toit

Daan du Toit

Deputy Director-General: ICR, Department of Science and Innovation
Daan du Toit started his career in the South African Government with the then Department of Foreign Affairs where he trained as a diplomat. Since 2002 he has been attached to the Department of Science and Innovation, where he has notably served as the Department's representative in... Read More →
avatar for Marcel Tanner

Marcel Tanner

President, Swiss Academy of Sciences, Professor Emeritus of Epidemiology, Swiss Tropical and Public Health Institute
Professor Marcel Tanner was Director of the Swiss Tropical and Public Health Institute from 1997 to 2015 and is now President of the Swiss Academy of Sciences. He holds a PhD in medical biology from the University of Basel and an MPH from the University of London. Lived and worked... Read More →
avatar for Leonardo Simão

Leonardo Simão

High Representative, Africa, EDCTP
Dr Leonardo Santos Simão is a medical doctor by training. After his graduation from the Eduardo Mondlane University, Mozambique in 1980, he worked in rural areas of Mozambique as a medical officer at district and provincial levels. He holds a Master’s degree in Public Health (Community... Read More →
avatar for Prof. Marleen Temmerman

Prof. Marleen Temmerman

Director, Aga Khan University, Kenya
Prof dr Marleen Temmerman is Chair of the Department of Obstetrics and Gynaecology, Aga Khan University Hospital and Director of the Center of Excellence in Women and Child Health, Aga Khan University (Nairobi, Kenya). Prior she was the Director of the Department of Reproductive Health... Read More →
avatar for Peter Kilmarx

Peter Kilmarx

Deputy Director, Fogarty International Center, National Institutes of Health, USA
Peter Kilmarx, an expert in global health and infectious disease research, policy, and programs, is the Deputy Director of the John E. Fogarty International Center of the National Institutes of Health, a preeminent center for global health research and capacity building. He previously... Read More →
avatar for Margareth Ndomondo-Sigonda

Margareth Ndomondo-Sigonda

Head, Health Unit, AUDA-NEPAD
Margareth Ndomondo-Sigonda, works for AUDA-NEPAD as Head of Health Program. She is responsible for providing technical lead and strategic oversight on health and pharmaceutical programs such as the African Medicines Regulatory Harmonization (AMRH) Initiative, the establishment of... Read More →
avatar for Nkandu Luo

Nkandu Luo

Professor
Professor Nkandu Luo is an internationally renowned scientist and seasoned politician. She has served in many consulting portfolios for various international organs, including UNDP, UNV, UNIFEMME, UN Women, Eastern, Central, Southern Health Community (ECSA), UNAIDS, Global Fund, and... Read More →
avatar for Magda Robalo Correia e Silva

Magda Robalo Correia e Silva

High Commissioner for COVID-19, High Commission for COVID-19
Magda Robalo is the High Commissioner for COVID-19 since June 2020, leading the national response to the pandemic in her home country, Guinea-Bissau. She was the Minister of Public Health in the first parity Government (2019-2020), served as World Health Organization’s (WHO) Representative... Read More →
avatar for Pedro Alonso

Pedro Alonso

Director Global Malaria Programme, World Health Organization (WHO)
Dr Pedro L. Alonso is the Director of the WHO Global Malaria Programme in Geneva, Switzerland. The Global Malaria Programme is responsible for the coordination of WHO's global efforts to control and eliminate malaria and sets evidence-based norms, standards, policies and guidelines... Read More →
avatar for Catarina Resende de Oliveira

Catarina Resende de Oliveira

President, Agency for Clinical Research and Biomedical Innovation (AICIB), Portugal
Catarina Resende de Oliveira, MD PhD, is Full Professor (Jubilada), at the Faculty of Medicine, University of Coimbra. She is past President of the Center for Neuroscience and Cell Biology (CNC, Associate Laboratory), in the same university, and coordinator of the “Unidade para... Read More →



Wednesday September 22, 2021 3:00pm - 6:00pm CEST